Seth Manilove

Seth Manilove

Goodwin

Contact
View Bio
RSS

Latest Posts › Drug Pricing

Share:

Year in Review: Top Regulatory Developments of 2024

As 2025 begins, we would like to reflect on last year’s regulatory developments in the biologics and biosimilars space. Here are some of the top regulatory developments from 2024....more

1/13/2025  /  Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Drug Pricing , Federal Trade Commission (FTC) , Food and Drug Administration (FDA) , Inflation Reduction Act (IRA) , Life Sciences , Medicare , Pharmaceutical Industry , Pharmacy Benefit Manager (PBM)
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide